Tirzepatide
GLP-1 / GIP Dual Agonist
Tirzepatide is a dual GLP-1 and GIP receptor agonist that has been extensively studied for its effects on metabolic function, body composition, and glycemic control. It is one of the most researched peptides in the GLP-1 class.
Available Sizes
Mechanism of Action
Simultaneously activates GLP-1 and GIP receptors, producing complementary effects on insulin secretion, glucagon suppression, and appetite regulation. The dual mechanism results in greater metabolic impact than GLP-1 agonism alone.
Research Highlights
- Dual GLP-1 and GIP receptor activation
- Robust body weight reduction in clinical research
- Significant HbA1c lowering in metabolic studies
- Improved cardiovascular risk markers
Product Specifications
Research Use Only. Tirzepatide is sold exclusively for in vitro research and laboratory use. It is not intended for human or veterinary consumption, therapeutic use, or any other purpose. By purchasing, you confirm you are a qualified researcher and will use this compound in compliance with all applicable laws.
